January 11, 2017—President-elect Trump said today that drug companies are “getting away with murder” as he promised to save the country billions of dollars through “new bidding procedures.” … [Read more...]

January 9, 2017—Cancer and orphan drugs that command high prices increasingly dominate drug company pipelines, a new study shows. … [Read more...]

January 4, 2017—The Department of Health and Human Services published a 340B program final rule today implementing fines for drug manufacturers that knowingly and intentionally overcharge safety-net healthcare providers. The rule also sets standards for calculating 340B ceiling prices. … [Read more...]

January 3, 2017—The Obama administration has cleared the 340B civil monetary penalties for manufacturers and ceiling price regulations for publication in the Federal Register. … [Read more...]

December 21, 2016—The 340B program mega-guidance was the chief concern of 340B Informed readers for the second year in a row. In an exact repeat of 2015, four of this year’s 10 most-popular stories were about the guidance, including our top story of 2016. The mega-guidance’s status remains “pending review” at the White House Office of Management and Budget. But with … [Read more...]

December 20, 2016—Nineteen Senate Democrats have signed a letter to President-elect Trump outlining five ways he can fulfill his campaign pledge, which he repeated last week, to lower prescription drug prices. … [Read more...]

December 15, 2016—Sen. Charles Grassley (R-Iowa) is urging President-elect Trump to work with Congress to deal with drug companies that game the system and engage in anti-competitive behavior. The Justice Department, meanwhile, has charged two drug company executives with conspiracy to fix prices, rig bids, and allocate customers, part of a broader investigation of white collar … [Read more...]